Parallel Advisors’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
BGI
LFCM
NAMI
Parallel Advisors's CLLS Position: Q1 2026 in Review
Parallel Advisors sold out of Cellectis (CLLS) in Q1 2026, closing a stake of 1,479 shares — an estimated $7.16K sold.
Parallel Advisors first reported a position in CLLS in Q2 2017 and held it in 18 quarters. The position peaked at $22K in Q4 2019. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.
- Parallel Advisors reported no remaining Cellectis position as of Q1 2026 after selling out during the quarter.
- Parallel Advisors sold 1,479 Cellectis shares in Q1 2026, an estimated $7.16K.
- Parallel Advisors first reported a position in Cellectis in Q2 2017 and held it in 18 quarters.
- Parallel Advisors's Cellectis position peaked at $22K in Q4 2019.
- 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.
Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.